Drimva

Tempus

Senior Scientist I, Applied Machine Learning and Generative AI, Pharma R&D

$140K–$210K

Boston +2 · Senior · Full-time · Posted Oct 20, 2026

Location
Boston
Chicago
New York City
Experience
A PhD plus 2+ years of relevant industry or postdoctoral experience, or a master’s degree with 2+ years of relevant experience plus an additional 2+ years of relevant industry or postdoctoral experience.
Education
PhD, or master’s degree with 2+ years of relevant experience.

About the job

Develops computational analyses, algorithms, causal models, and AI tools that support pharmaceutical research and drug development on the Tempus platform.

What you'll do

  • Build and improve machine learning, generative AI, causal modeling, and agent-based capabilities for pharmaceutical R&D.
  • Collaborate with Tempus teams and pharmaceutical partners to develop solutions and communicate scientific findings to stakeholders.
  • Coach computational biology and real-world evidence scientists on AI tools and adoption.

What they ask for

  • PhD, or a master’s degree with 2+ years of relevant experience, plus an additional 2+ years of relevant industry or postdoctoral experience.
  • Quantitative/computational skills in causal AI, causal inference, or explainable AI, along with biological, medical, or drug-development knowledge.
  • Proficiency in R, Python, and SQL; machine learning and statistical modeling expertise, including hands-on causal methods.
  • Experience with LLM-driven agent architectures, prompt engineering, RAG, and function calling/tool use; peer-reviewed publications.

Nice to have

  • Integrative modeling of multimodal clinical and omics data.
  • Understanding of cancer biology and experience with transcriptome, NGS, clinical, or real-world medical data.

Pay

$140,000-$200,000 USD base salary; $150,000-$210,000 USD base salary

Tools

R, Python, SQL, LangChain, LangGraph, AutoGen, DSPy

AI focus

Develops and applies machine learning, causal AI, generative AI, LLM agents, and foundation models for pharmaceutical R&D.

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 5, 2026 (UTC)